MBM-5

N/A

Report date: 2025/01/15 11:02:59
NME

Base Information

Drug NameMBM-5
Drug Alias NameMBM-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase NEK2 inhibitors
TargetsSerine/threonine-protein kinase NEK2
Therapy Area/IndicationsColorectal NeoplasmsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEast China Normal University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A